Page 2 - Swedish (OMX) Growth Healthcare Stocks

UPDATED Apr 21, 2024

Discover Swedish Healthcare Growth Stocks that are on the OMX. Sorted by forecasted growth, these Healthcare Stocks have higher than expected earnings or sales growth compared to other companies.

97 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

RAY B

RaySearch Laboratories
kr114.00-2.1%54.1%kr3.9bkr135.00PE47.9xE34.7%0.6%

XVIVO

Xvivo Perfusion
kr316.50-4.7%11.6%kr10.0bkr389.83PE108.6xE34.6%n/a

CRAD B

C-Rad
kr40.103.5%27.1%kr1.4bkr58.00PE29.3xE30.0%n/a

EPIS B

Episurf Medical
kr0.710.9%-62.6%kr189.6mkr2.50PS18.4xE24.3%n/a

BOUL

Boule Diagnostics
kr9.864.4%-19.8%kr382.9mkr10.40PE15.3xE23.7%0%

CEVI

CellaVision
kr224.503.5%37.4%kr5.4bkr257.50PE41.1xE23.0%1.0%

ATT

Attendo
kr47.656.4%40.1%kr7.6bkr55.00PE20.2xE22.6%2.1%

SUS

Surgical Science Sweden
kr144.70-9.7%-21.4%kr7.4bkr221.50PE31.6xE22.0%n/a

ARJO B

Arjo
kr46.40-11.6%5.5%kr12.6bkr51.25PE26.3xE20.5%1.9%

CARE

Careium
kr25.705.8%62.7%kr625.2mkr28.50PE16.5xE19.5%n/a

HUM

Humana
kr25.45-4.5%84.7%kr1.2bkr33.50PE6.9xE18.2%0%

ADDV A

ADDvise Group
kr13.050%-12.7%kr1.5bkr23.00PE23.4xE15.8%0%

SECT B

Sectra
kr207.80-1.2%24.4%kr40.0bkr150.00PE94.3xE15.7%0.5%

AMBEA

Ambea
kr63.95-1.8%72.8%kr5.7bkr79.67PE12.6xE15.4%2.3%

EKTA B

Elekta
kr74.45-4.4%-13.7%kr28.4bkr83.42PE19.9xE14.5%3.2%

CMOTEC B

Scandinavian ChemoTech
kr2.24-8.2%-52.8%kr40.2mkr2.60PS14.2xE13.3%n/a

GETI B

Getinge
kr212.80-0.7%-20.8%kr58.0bkr225.50PE24xE12.2%2.1%

DEDI

Dedicare
kr99.90-1.1%-23.7%kr955.3mkr120.00PE8.7xE1.7%6.5%

IMP A SDB

Implantica
kr29.00-3.0%53.8%kr8.2bkr42.95PS500.7xE-3.7%n/a

SDET

SensoDetect Aktiebolag
kr0.120%-70.8%kr35.7mn/aPS15.8xn/an/a

CRBX

Carbiotix
kr0.063-4.9%-97.9%kr11.3mn/aPS2.6xn/an/a

LXB

Luxbright
kr0.92-15.6%42.9%kr84.8mn/aPS99.2xn/an/a

HEART

Scandinavian Real Heart
kr0.8335.0%-68.7%kr80.1mn/aPB1xn/an/a

CMH

Chordate Medical Holding
kr0.0584.7%-88.1%kr28.1mn/aPS16.1xn/an/a
Page 2 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.